EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neoadjuvant chemotherapy reduces regulatory T-cells in cervical cancer

Jelena M Meek, Iske F van Luijk, Mark A J Gorris, Corneel Coens, Evgenia Martynova, Thomas J van Ee, Antonio Casado, Helena C van Doorn, Ignace Vergote, I Jolanda M de Vries, Gemma G Kenter, Petronella B Ottevanger

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2026.116984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Jelena M Meek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: Jelena.meek@radboudumc.nl. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Neoadjuvant Therapy, T-Lymphocytes, Regulatory, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Organisation for Research and Treatment of Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsNeoadjuvant TherapyT-Lymphocytes, RegulatoryAntineoplastic Combined Chemotherapy ProtocolsLymphocytes, Tumor-InfiltratingHumansFemaleTumor MicroenvironmentMiddle AgedAdultCisplatinChemotherapy, AdjuvantAgedTreatment Outcome

Stichwörter der Autor:innen

Cervical cancerImmunotherapyMultiplex immunohistochemistryNeoadjuvant chemotherapyRegulatory T-cellsTumor microenvironment

Substanzen

Cisplatin

Autor:innen und Institutionen

  • Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: Jelena.meek@radboudumc.nl.
  • Department of Gynaecology. Haaglanden Medical Center, The Hague, the Netherlands; Center Gynaecologic Oncology Amsterdam, Amsterdam, the Netherlands.
  • Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands; Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, the Netherlands.
  • Medical Oncology, University Hospital San Carlos, Madrid, Spain.

Förderung

  • European Organisation for Research and Treatment of Cancer

Zitieren

APA

Meek, J. M., van Luijk, I. F., Gorris, M. A. J., Coens, C., Martynova, E., van Ee, T. J., Casado, A., van Doorn, H. C., Vergote, I., de Vries, I. J. M., Kenter, G. G., & Ottevanger, P. B. (2026). Neoadjuvant chemotherapy reduces regulatory T-cells in cervical cancer. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116984

Vancouver

Meek JM, van Luijk IF, Gorris MAJ, Coens C, Martynova E, van Ee TJ, et al. Neoadjuvant chemotherapy reduces regulatory T-cells in cervical cancer. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116984

BibTeX
@article{Meek2026,
  author = {Meek, Jelena M and van Luijk, Iske F and Gorris, Mark A J and Coens, Corneel and Martynova, Evgenia and van Ee, Thomas J and Casado, Antonio and van Doorn, Helena C and Vergote, Ignace and de Vries, I Jolanda M and Kenter, Gemma G and Ottevanger, Petronella B},
  title = {Neoadjuvant chemotherapy reduces regulatory T-cells in cervical cancer},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2026.116984}
}
Kostenlos starten →